BioScrip Investors' Attys Win $2.7M In Fees From $11M Deal
A New York federal judge on Wednesday granted Bernstein Litowitz Berger & Grossman LLP's request for $2.7 million in attorneys' fees from BioScrip Inc. after getting the specialty pharmacy to pay...To view the full article, register now.
Already a subscriber? Click here to view full article